Pharmafile Logo
Pharmafocus logo
Advanced Search

The downfall of COVID-19 lies in new generation anti-viral drugs, says WHO

January 28, 2022
Medical Communications

In a BBC News interview, WHO shared their views against easing pandemic restrictions, as new variants flare up anywhere until …

News

Oncology history: Immunocore claims first-ever FDA approval of melanoma drug

January 27, 2022
Business Services

Immunocore has claimed a piece of history in biotech industry, becoming the first company to secure an FDA approval for …

News

Gilead combo therapy hit with FDA hold over serious adverse events

January 27, 2022
Business Services

The FDA has placed a partial clinical hold on studies conducted by Gilead Sciences assessing the combination of magrolimab plus …

News
isaac-quesada-sij6sanetye-unsplash

Face mask rules and COVID-19 passes end in England, care home restrictions ease

January 27, 2022
Business Services

The government has announced that there will be no limit on the number of visitors to care homes in England. …

News

Medidata partners with Circuit Clinical to strengthen clinical trial capabilities

January 27, 2022
Business Services

Medidata has announced a partnership with Circuit Clinical to strengthen its decentralised clinical trial (DCT) capabilities. Circuit Clinical has created …

News

FDA clearance of Investigational New Drug Application for novel peanut allergy vaccine

January 26, 2022
Research and Development

Allergy Therapeutics has announced the FDA clearance of the Investigational New Drug Application (IND) for its novel virus-like particle (VLP)-based …

News

Highest UK COVID-19 deaths since February as Pfizer begin trials for Omicron jab

January 26, 2022
Research and Development

Pfizer has begun clinical trials for its new COVID-19 vaccine tailored to the Omicron variant, and has shared that it …

News

Maxim Biomedical receives EUA for ClearDetect COVID-19 antigen home test

January 26, 2022
Research and Development

Maxim Biomedical have received an Emergency Use Authorisation (EUA) from the FDA for their new ClearDetect COVID-19 Antigen Home Test. …

News

New study highlights cell power as a functional biomarker for preventing tumour escape

January 26, 2022
Research and Development

LUMICKS announced that new research findings published in Translational Medicine detailed a novel design strategy for preventing tumour escape through …

News

FDA grants Evrysdi priority review for treatment of spinal muscular atrophy in infants

January 25, 2022
Manufacturing and Production

The FDA has granted priority review of a supplemental new drug application (sNDA) for Evrysdi (risdiplam), to expand the indication …

News
credit_-_crevis_shutterstock_340710245_720

Significantly reduced tumour growth with new candidate

January 25, 2022
Manufacturing and Production

Spago Nanomedical AB announced new clinical and preclinical results for the company’s leading candidate drug, Tumorad® (177Lu-SN201). In a preclinical …

News

Bimzelx approved in Japan for treatment of multiple types of psoriasis

January 25, 2022
Manufacturing and Production

UCB announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted marketing authorisation for BIMZELX (bimekizumab) for …

News

FDA restrict use of two monoclonal antibody treatments

January 25, 2022
Manufacturing and Production

The FDA has shared that it is limiting the use of two monoclonal antibody therapies for the treatment of COVID-19, …

News

Ascletis begins Phase III trial into bevacizumab for treatment of recurrent glioblastoma

January 24, 2022
Sales and Marketing

Ascletis Pharma has announced the dosing of the first patient in the Phase III registration clinical trial of ASC40, combined …

News

Pfizer: Annual COVID shots preferable to frequent boosters

January 24, 2022
Sales and Marketing

Pfizer CEO Albert Bourla has commented that an annual COVID-19 vaccine would be preferable to more frequent booster shots in …

News

NICE expands guidance for lokelma in adult patients with persistent hyperkalaemia

January 24, 2022
Sales and Marketing

NICE have updated the Technology Appraisal Guidance (TAG) for Lokelma (sodium zirconium cyclosilicate SZC) in the treatment of adult patients …

News

Veklury obtains FDA approval for COVID-19 outpatients

January 24, 2022
Sales and Marketing

The FDA has granted expedited approval of a supplemental new drug application (sNDA) for Veklury (remdesivir) for he treatment of …

News

EU health ministers consider fourth COVID-19 vaccine dose

January 21, 2022
Medical Communications

European Union health ministers will try to find a common line on Friday over a potential fourth dose of COVID-19 …

News

Amid plans to ease COVID restrictions, dialysis patients remain vulnerable to Omicron

January 21, 2022
Medical Communications

As the government in England relaxes COVID-19 restrictions, new data from the Francis Crick Institute raise concerns over the impact …

News

Artificial pancreas may prove life-changing for young children with diabetes

January 21, 2022
Medical Communications

Cambridge researchers have developed an artificial pancreas which may beat standard treatment in controlling Type 1 diabetes in young children. …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025